Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Natural Killer Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT06508489
What this trial is testing

Investigate Natural Killer Cell Engager (SAR443579) With Different Agents in Participants With Hematological Malignancies

Who this might be right for
Acute Myeloid Leukemia
Sanofi 7
Not applicableEnded earlyNCT01558882
What this trial is testing

Impact of Essure Tubal Sterilization Devices on the Endometrium

Who this might be right for
Sterilization, Tubal
Centre Hospitalier Universitaire de Nīmes 2
Testing effectiveness (Phase 2)Looking for participantsNCT06966154
What this trial is testing

A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL

Who this might be right for
Natural Killer/T-cell LymphomaRelapsed or Refractory Lymphoma Including ENKL
Fudan University 68
Early research (Phase 1)Study completedNCT04280224
What this trial is testing

NK Cells Treatment for COVID-19

Who this might be right for
Novel Coronavirus Pneumonia
Henan Medical University 2
Not applicableLooking for participantsNCT05676190
What this trial is testing

Clinical Study on the Efficacy of Autologous Cell Factor Induced Killer Cells in the Treatment of Colorectal Cancer

Who this might be right for
Colorectal Cancer
ShiCang Yu 80
Early research (Phase 1)Study completedNCT00076180
What this trial is testing

Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia

Who this might be right for
T-Cell Large Granular Lymphocytic LeukemiaLeukemia, T-Cell Large Granular Lymphocytic
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04127227
What this trial is testing

Sintilimab With P-GemOx Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-cell Lymphoma, Nasal Type

Who this might be right for
NK/T Cell Lymphoma Nos
Sun Yat-sen University 34
Not applicableNot Yet RecruitingNCT07831161
What this trial is testing

Safety and Efficacy of Autologous Natural Killer Cell Therapy (CHANK-101) in Patients With Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Dong-A University Hospital 60
Testing effectiveness (Phase 2)UnknownNCT05272293
What this trial is testing

Immunotherapy With ex Vivo Expanded Haploidentical Natural Killer Cells for Children/Young Adults With AML

Who this might be right for
Acute Myeloid Leukemia
Belarusian Research Center for Pediatric Oncology, Hematology and Immunology 15
Testing effectiveness (Phase 2)Study completedNCT02161198
What this trial is testing

Efficacy and Safety Study of Ginseng Polysaccharide Extract

Who this might be right for
Healthy
Seoul St. Mary's Hospital 72
Testing effectiveness (Phase 2)Study completedNCT03050216
What this trial is testing

QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML

Who this might be right for
Acute Myeloid Leukemia
Masonic Cancer Center, University of Minnesota 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT02490748
What this trial is testing

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
The First People's Hospital of Changzhou 10
Testing effectiveness (Phase 2)UnknownNCT05334693
What this trial is testing

Expanded Haploidentical Natural Killer Cells as Consolidation Strategy for Children/Young Adults With AML

Who this might be right for
Acute Myeloid Leukemia
Belarusian Research Center for Pediatric Oncology, Hematology and Immunology 15
Very early researchLooking for participantsNCT06643221
What this trial is testing

Exercise as an Immune Adjuvant for Allogeneic Cell Therapies

Who this might be right for
LeukemiaHematopoetic Stem Cell TransplantationDonor Lymphocyte Infusion+3 more
University of Arizona 200
Not applicableUnknownNCT06727383
What this trial is testing

CAR-NK Cells Production and Expansion From Patients With Lympho or Myeloproliferative Disorders and From Healthy Donors

Who this might be right for
Healthy DonorsMyeloproliferative DiseasesLymphoproliferative Disorders
European Institute of Oncology 140
Not applicableStudy completedNCT00002061
What this trial is testing

A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Immunodepressed Patients With Uncomplicated Generalized Lymphadenopathy

Who this might be right for
Lymphatic DiseaseHIV Infections
Newport Pharmaceuticals International
Early research (Phase 1)Study completedNCT04900454
What this trial is testing

Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19

Who this might be right for
COVID-19 Pneumonia
Coeptis Therapeutics 12
Not applicableStudy completedNCT02954783
What this trial is testing

PROstaTe Cancer - Exercise-STudy (PRO-TEST)

Who this might be right for
Prostate Cancer
Rigshospitalet, Denmark 30
Testing effectiveness (Phase 2)Looking for participantsNCT07480928
What this trial is testing

Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Unresectable Locally Advanced or Metastatic Disease
Beijing Biotech 42
Testing effectiveness (Phase 2)Ended earlyNCT03387098
What this trial is testing

QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy

Who this might be right for
Pancreatic Cancer
ImmunityBio, Inc. 4
Next Page